ID   HeLa/PTX
AC   CVCL_HF87
DR   Wikidata; Q54882700
RX   PubMed=25015454;
CC   Population: African American.
CC   Doubling time: 32.5 +- 2.21 hours (PubMed=25015454).
CC   Selected for resistance to: ChEBI; CHEBI:45863; Paclitaxel (Taxol).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 05-10-23; Version: 8
//
RX   PubMed=25015454;
RA   Bi W.-X., Wang Y.-X., Sun G.-Y., Zhang X.-J., Wei Y.-Q., Li L.,
RA   Wang X.-Y.;
RT   "Paclitaxel-resistant HeLa cells have up-regulated levels of reactive
RT   oxygen species and increased expression of taxol resistance gene 1.";
RL   Pak. J. Pharm. Sci. 27:871-878(2014).
//